Giuseppe Lippi/LinkedIn
Oct 10, 2025, 03:09
Giuseppe Lippi: We Show Here That Red Light Therapy Offers Promise in High-Risk Patients
Giuseppe Lippi, Dean of Medicine at the University of Verona, shared on LinkedIn:
”We show here that red light therapy offers promise in high-risk patients where conventional anticoagulation is limited by bleeding risk.
Fan BE, Pasalic L, Lippi G, Hew YY, Favaloro EJ. Red Light Therapy in Thrombosis and Hemostasis. Semin Thromb Hemost. 2025 Oct 8. doi: 10.1055/a-2717-5157. Epub ahead of print.”
Read the full article in Seminars in Thrombosis and Hemostasis.
Article: Red Light Therapy in Thrombosis and Hemostasis
Authors: Bingwen Eugene Fan , Leonardo Pasalic, Giuseppe Lippi , Yu Yue Hew, Emmanuel J. Favaloro
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Mar 13, 2026, 13:10Hisam Siddiqi: Is FFP Really The Magic Elixir of All Coagulopathies in Liver Disease
-
Mar 13, 2026, 13:08Lena Volland: Screening Gaps and Clinical Outcomes of Iron Deficiency Anemia in Pregnancy
-
Mar 13, 2026, 13:05Sebastian Szmit: Managing Venous Thromboembolism and Anticoagulation in Cancer Patients
-
Mar 13, 2026, 12:43Annie Bauzon: HbA1c Insights and Clinical Importance in Diabetes Management
-
Mar 13, 2026, 12:41Ifeanyichukwu Ifechidere: Anaemia is not a Diagnosis – It’s a Symptom
-
Mar 13, 2026, 12:18Abdallah Othman: Arterial Blood Supply of the Cardiac Conduction System
-
Mar 13, 2026, 12:14Roshni Kulkarni: Honoring Women and Girls Living With Bleeding Disorders
-
Mar 13, 2026, 11:48Kausik Ray: Efficacy and Safety of Obicetrapib in Patients With HeFH on Maximally Tolerated Statins
-
Mar 13, 2026, 11:36Alfonso Tafur: The Data Behind Cancer-Associated Thrombosis